Dr. Michael Van Ameringen
Michael Van Ameringen, MD, FRCPC, is a Professor in the Department of Psychiatry and Behavioural Neurosciences. His current research is focused on the psychopharmacology of Anxiety Disorders and comorbid Mood Disorders, Obsessive Compulsive and Related Disorders, the relationship between the gut microbiome and OCD, Social Anxiety Disorder, Generalized Anxiety Disorder and treatment resistance. Other research interests include the use of mobile mental health apps, trans-diagnostic internet-based CBT (iCBT), computer-assisted CBT for children at risk of an anxiety disorder and the treatment of ADHD with comorbidity. He has been a member of the Steering Committee for the development of the original and updated versions of the Canadian Anxiety Disorder Treatment Guidelines.
As well, he was a member of the World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders. He is a member of the Board of Directors and the Scientific Council of the Anxiety and Depression Association of America and is on the editorial board for the journal Depression and Anxiety. He is also on the Board of Directors for the International College of Obsessive Compulsive Spectrum Disorders. Dr. Van Ameringen has published widely in the area of OCD and Anxiety Disorders.